Sleep and Circadian Mechanisms in Hypertension
NCT05184933
Cardiovascular Diseases, Cardiovascular Risk Factors
Portland, Oregon, United States
View Trial DetailsNCT Number: NCT05169333
ORFAN is a prospective, multi-centre, multi-ethnic cohort observational study collecting CT scans, biological material and outcomes data, to develop and validate novel biomarkers of cardiometabolic and other disease risk.
Interested in participating?
Request Info18 year–99 year
All sexes
Observational
Flinders University, Adelaide, Australia
The ORFAN registry will include unselected, consecutive patients undergoing CT scans (coronary CT angiograms (CCTA), CT chest, abdomen and pelvis scans) collected at the participating centres. The study will combine imaging data with patient demographics and clinical information (including prospective outcomes) to aid the development and/or validation of new or existing image analysis algorithms and software tools to improve diagnosis, clinical risk discrimination and prediction. Specifically, ORFAN will evaluate the specificity, utility and predictive value of newly developed image analysis methods. ORFAN will recruit and follow-up patients prospectively, linking the index CT scan with blood biomarkers, genetic information as well as information on disease progression (recorded through follow-up CT scans) and clinical outcomes data.
The study will also collect CT scans performed in the past and link them with clinical factors and prospective outcomes data collected after the index scan was performed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Inclusion criteria
for study Arms 1, 2 and 3:
Inclusion criteria
for study Arm 4:
Exclusion criteria
Exclusion criteria
for Study Arms 1, 2 and 3:
Exclusion criteria
for Study Arm 4:
Time frame: 15 years
Using novel image analysis methods, clinical risk factors, and blood biomarkers to predict future cardiac and all-cause mortality over a period of 15 years post CT scan.
Time frame: 15 years
Using novel image analysis methods, clinical risk factors, and blood biomarkers to predict future non-fatal vascular events over a period of 15 years post CT scan.
Time frame: 15 years
Using novel image analysis methods, clinical risk factors, and blood biomarkers to detect pathology from Computed Tomography images.
Time frame: 15 years
Using novel image analysis methods, clinical risk factors, and blood biomarkers to predict progression of cardiometabolic diseases over a period of 15 years post index CT scan.
Time frame: 15 years
Using novel image analysis methods and blood biomarkers, to detect and monitor cardiovascular risk factors and responsiveness to routine clinical care
Time frame: 15 years
Using novel image analysis methods, to predict hospital admissions over a period of 15 years post CT scan
Time frame: 15 years
Using genotyping to predict clinical phenotypes
Time frame: 15 years
Using novel image analysis methods, clinical risk factors, and blood biomarkers to predict disease progression measured by CT scans
Time frame: 15 years
Validate the prognostic and diagnostic performance of CaRi Image analysis platform against the other study outcomes
Contact information is provided by the study sponsor or research team.
University of Oxford
Other
Acronym: ORFAN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05184933
Cardiovascular Diseases, Cardiovascular Risk Factors
Portland, Oregon, United States
View Trial DetailsNCT06919302
Cardiovascular Diseases, Cardiovascular Risk Factors
Toronto, Ontario, Canada
View Trial DetailsNCT03805529
Cardiovascular Diseases, Cardiovascular Health
Milwaukee, Wisconsin, United States
View Trial DetailsNCT00848380
Cardiovascular Diseases, Cardiovascular Risk Factors
Frick, Canton of Aargau, Switzerland
View Trial Details